recombin
vesicular
stomat
virus
rvsv
develop
potenti
vaccin
candid
character
vivo
replic
dissemin
rvsv
vector
mice
high
dose
highli
attenu
vector
express
gag
rvsv
prototyp
refer
viru
rvsv
deliv
intramuscularli
im
intranas
intraven
iv
use
quantit
realtim
rtpcr
qpcr
standard
plaqu
assay
measur
tempor
dissemin
virus
variou
tissu
follow
im
inocul
virus
detect
primarili
inject
site
well
drain
lymph
node
neither
viru
induc
signific
weight
loss
patholog
sign
evid
neuroinvas
contrast
follow
inocul
prototyp
viru
detect
tissu
test
caus
signific
weight
loss
lead
death
administr
rvsv
result
detect
numer
tissu
brain
lung
nasal
turbin
lymph
node
albeit
significantli
reduc
level
caus
littl
weight
loss
mortal
follow
iv
inocul
prototyp
attenu
virus
detect
qpcr
tissu
test
contrast
prototyp
rvsv
viral
load
significantli
lower
organ
test
infecti
viru
detect
brain
follow
iv
inocul
despit
presenc
viral
rna
studi
demonstr
signific
differ
biodistribut
pattern
associ
pathogen
engend
prototyp
attenu
vector
highli
suscept
host
vesicular
stomat
viru
vsv
prototyp
viru
rhabdovirida
famili
belong
order
mononegaviral
encompass
singl
strand
nonseg
negativesens
rna
virus
highli
conserv
gene
order
two
common
serotyp
vsv
western
hemispher
design
indiana
vsv
new
jersey
vsv
nj
natur
vsv
infect
livestock
caus
selflimit
diseas
although
natur
occur
correspond
author
mail
address
north
middletown
road
pearl
river
ny
phone
fax
wyethcom
author
contribut
equal
work
current
address
iavi
street
brooklyn
ny
current
address
profectu
bioscienc
inc
white
plain
road
suit
tarrytown
ny
current
address
cdc
clifton
road
atlanta
ga
human
infect
vsv
rare
vsv
infect
report
individu
directli
expos
infect
livestock
within
laboratori
environ
live
within
endem
region
vsv
infect
human
typic
either
asymptomat
caus
mild
influenzalik
ill
among
small
mammal
mice
readili
infect
experiment
via
varieti
inocul
rout
thu
serv
tractabl
model
immunogen
pathogen
neurotrop
neurovirul
studi
vsv
shown
promis
vaccin
vector
wide
varieti
human
pathogen
includ
hiv
papilloma
viru
respiratori
syncyti
viru
sar
coronaviru
ebola
viru
marburg
viru
herp
simplex
viru
lassa
fever
viru
influenza
viru
review
see
hepat
c
viru
studi
conduct
prototyp
recombin
vsv
rvsv
vector
deriv
tissu
culturepassag
wild
type
wt
vsv
strain
shown
somewhat
attenu
compar
wt
vsv
recent
nonhuman
primat
model
neurovirul
show
prototyp
rvsv
vector
caus
signific
level
neuropatholog
follow
direct
intrathalam
inject
albeit
reduc
level
compar
wild
type
viru
observ
led
conclus
prototyp
rvsv
vector
requir
attenu
preclin
analysi
prior
clinic
evalu
process
gener
rvsv
reduc
vector
pathogen
develop
highli
attenu
rvsv
vector
express
gag
gene
rvsv
made
combin
three
attenu
approach
insert
gag
gene
first
posit
genom
shuffl
vsv
n
gene
fourth
posit
use
vsv
g
cytoplasm
tail
truncat
amino
acid
establish
gradient
transcript
vsv
gene
proxim
singl
genom
promot
express
highest
level
decreas
transcript
gene
distanc
promot
increas
anticip
high
level
gag
express
concomit
reduct
vsv
n
express
high
degre
attenu
rvsv
vector
compar
prototyp
rvsv
inde
vivo
attenu
rvsv
character
dramat
rise
mous
ld
follow
intracrani
ic
inocul
howev
vector
retain
abil
grow
vitro
high
titer
capabl
induc
immun
respons
mice
macaqu
compar
obtain
prototyp
vector
unpublish
observ
import
aspect
character
potenti
vaccin
vector
determin
pathogen
tissu
distribut
follow
vivo
administr
notabl
experi
administr
rvsv
vector
human
human
infect
vsv
occur
known
tissu
affect
infect
spread
therefor
assess
vivo
distribut
replic
prototyp
rvsv
attenu
rvsv
rvsv
vector
mice
follow
three
differ
rout
administr
intramuscular
im
intranas
intraven
iv
im
rout
chosen
consid
clinic
evalu
furthermor
test
iv
rout
evalu
effect
widespread
dissemin
virus
increas
stringenc
paramet
use
high
dose
rvsv
vector
studi
plaqu
form
unit
pfu
per
anim
anim
care
procedur
conform
institut
anim
care
use
committe
guidelin
facil
fulli
accredit
american
associ
accredit
laboratori
anim
care
six
seven
week
old
inbr
femal
balbc
mice
obtain
tacon
farm
germantown
ny
acclim
one
week
prior
inocul
transpond
biomed
data
system
inc
rockvil
md
use
identifi
mice
aid
record
bodi
weight
temperatur
insert
subcutan
back
mice
per
manufactur
instruct
cours
studi
mice
close
monitor
sign
neurolog
diseas
paralysi
seizur
mice
exhibit
sign
physic
disabl
inact
stimul
seizur
complet
paralysi
euthan
rvsv
rvsv
virus
previous
describ
prepar
viral
stock
inocul
mice
babi
hamster
kidney
cell
bhk
infect
viru
multipl
infect
moi
rvsv
viru
harvest
hour
rvsv
viru
harvest
hour
harvest
cultur
media
first
subject
lowspe
centrifug
rpm
min
beckman
refriger
centrifug
supernat
layer
onto
sucros
cushion
follow
ultracentrifug
rpm
min
beckman
rotor
media
sucros
discard
viral
pellet
resuspend
phosphat
buffer
salin
pb
mediatech
aliquot
reconstitut
virus
frozen
dri
iceethanol
bath
store
frozen
determin
potenc
viru
stock
aliquot
thaw
titer
vero
cell
duplic
accord
procedur
immedi
prior
anim
inocul
frozen
viru
stock
rapidli
thaw
min
briefli
mix
vortex
place
immedi
ice
base
concentr
viru
dilut
pb
concentr
pfudos
pb
use
neg
control
group
mice
im
inocul
mice
anesthet
ip
inject
ketamin
mgkg
xylazin
mgkg
dilut
steril
salin
im
inocul
mous
given
one
inject
right
calf
muscl
inocul
mous
given
two
dose
nose
paus
inocul
ensur
proper
uptak
nasal
passag
iv
inocul
mice
care
warm
heat
lamp
mous
given
one
inject
later
tail
vein
health
statu
mice
record
studi
durat
day
group
mice
weight
bodi
temperatur
record
daili
two
week
mice
becom
bilater
paralyz
show
sign
distress
sever
ill
euthan
record
succumb
vsv
diseas
tissu
harvest
transcardi
perfus
salin
anim
remov
bloodassoci
vsv
harvest
organ
perfus
perform
mice
receiv
vsv
im
previou
studi
show
vsv
viremia
follow
inocul
rout
mice
either
euthan
inhal
co
im
studi
anesthet
describ
perfus
iv
studi
latter
case
death
achiev
exsanguin
caus
perfus
perfus
anim
place
dorsal
recumb
abdomen
wet
alcohol
incis
made
abdomin
midlin
thorac
caviti
open
expos
heart
lung
gaug
needl
attach
fluid
bag
contain
pb
iv
set
needl
put
apex
left
ventricl
fluid
line
open
fulli
right
auricl
snip
suffici
fluid
maximum
ml
allow
pump
vasculatur
evacu
blood
anim
follow
organ
harvest
mice
test
presenc
vsv
rna
viru
brain
liver
lung
kidney
spleen
muscl
correspond
inject
site
im
rout
im
iv
studi
nasal
turbin
studi
drain
lymph
node
poplit
inguin
iliac
im
cervic
blood
also
collect
time
organ
harvest
prior
perfus
piec
tissu
weigh
suspend
phosphatebuff
salin
pb
sucros
phosphat
buffer
glutamin
spbg
sucros
k
hpo
kh
po
glutam
acid
weightvolum
wv
homogen
use
omni
tip
tissu
homogen
kit
autoclav
probe
lymph
node
nasal
turbin
resuspend
directli
ml
pbsspbg
produc
approxim
wv
suspens
determin
viral
load
aliquot
remov
store
rna
extract
viru
titrat
viral
nucleic
acid
extract
homogen
tissu
use
rneasi
mini
kit
qiagen
valencia
ca
revers
transcrib
cdna
use
method
previous
describ
briefli
detect
viral
genom
rna
neg
sens
done
reaction
mix
contain
total
rna
tissu
sampl
vsv
n
larg
ribosom
protein
housekeep
gene
rplo
forward
primer
reagent
sensiscript
revers
transcriptas
kit
qiagen
detect
mrna
transcript
anchor
oligodt
primer
substitut
vsv
n
specificforward
primer
otherwis
reagent
condit
revers
transcript
step
remain
describ
primer
probe
set
detect
rna
encod
vsv
n
hiv
gag
primer
nucleotid
sequenc
anchor
oligodt
primer
previous
describ
primerprob
set
rplo
select
use
primer
express
softwar
version
appli
biosystem
foster
ca
contain
follow
sequenc
forward
primer
anneal
residu
revers
primer
anneal
residu
taqman
probe
anneal
residu
duplex
quantit
realtim
pcr
detect
genom
rna
carri
use
quantitect
multiplex
pcr
kit
qiagen
pcr
reaction
contain
dilut
vsv
n
hiv
gag
rplo
cdna
use
gener
standard
curv
cdna
tissu
sampl
quantitect
multiplex
pcr
master
mix
nm
forward
revers
primer
vsv
n
rplo
nm
probe
duplex
assay
detect
mrna
cdna
reaction
mix
remain
except
hiv
gag
rplo
forward
revers
primer
probe
use
order
distinguish
amplicon
probe
vsvn
label
fam
hivgag
vic
rplo
ned
amplif
detect
perform
abi
prism
fast
realtim
pcr
system
use
follow
condit
min
activ
hotstar
taq
dna
polymeras
follow
cycl
sampl
test
duplic
calcul
group
mean
detect
limit
use
sampl
limit
detect
assay
tissu
copiesml
blood
briefli
titer
viru
determin
perform
serial
dilut
sampl
dmem
supplement
fb
onetenth
volum
serial
dilut
ml
use
infect
confluent
vero
cell
monolay
plate
sampl
infect
duplic
well
ad
ml
fb
per
well
infect
cell
incub
room
temperatur
rt
min
follow
min
co
incub
inoculum
remov
well
replac
ml
sea
plaqu
agaros
cambrex
fb
overlay
plate
incub
incub
plaqu
format
hour
agaros
plug
care
remov
small
spatula
monolay
fix
methanol
aceton
mixtur
ml
per
well
rt
min
wash
pb
ml
block
solut
milk
tri
buffer
salin
ttb
ad
well
incub
rt
min
follow
pb
wash
monolay
incub
rt
hour
ml
per
well
primari
antibodi
mixtur
mab
dilut
ttb
monolay
wash
pb
incub
rt
min
secondari
antibodi
horseradish
peroxidaseconjug
goat
antimous
igg
biorad
dilut
ttb
follow
pb
wash
monolay
incub
rt
min
ml
per
well
dab
substrat
one
tablet
sigma
ml
pb
h
count
stain
plaqu
viru
titer
calcul
mean
homogen
tissu
pfuml
blood
calcul
group
mean
detect
limit
use
sampl
limit
detect
assay
tissu
pfuml
blood
data
express
mean
sem
five
mice
per
test
group
appropri
statist
comparison
conduct
logtransform
data
use
twotail
unpair
test
case
observ
one
group
limit
detect
fisher
exact
test
use
valu
p
consid
statist
signific
degre
signific
repres
figur
p
p
p
whole
brain
fix
formalin
immedi
follow
necropsi
mous
transvers
h
estain
tissu
section
olfactori
lobe
ol
cerebrum
level
corpu
callosum
cerebrum
level
optic
chiasm
cerebellum
medulla
oblongata
level
paraflocculu
examin
board
certifi
veterinari
pathologist
section
evalu
follow
diagnost
criteria
inflamm
perivascular
cuf
inflammationdegener
neuronalneuropil
gliosi
inflammationdegener
ventricularperiventricular
inflamm
mening
degener
axon
myelin
vacuol
neuropil
diagnost
criteria
subject
sever
score
assign
use
scale
normal
chang
present
chang
present
minim
sever
chang
present
mild
sever
chang
present
moder
sever
chang
present
mark
sever
chang
present
sever
previou
studi
shown
highli
attenu
vector
rvsv
hereaft
refer
greatli
reduc
neurovirul
yet
retain
potent
immunogen
mice
compar
prototyp
vector
rvsv
hereaft
refer
better
understand
viru
dissemin
follow
vaccin
perform
seri
studi
compar
tissu
distribut
two
vector
mice
follow
high
dose
pfu
administr
im
iv
rout
initi
studi
design
includ
tissu
harvest
day
hour
postinocul
postinocul
viral
load
assess
howev
persist
viral
rna
tissu
day
im
studi
addit
later
time
point
collect
iv
studi
mice
inocul
im
rout
pb
control
monitor
clinic
two
week
mice
group
lost
averag
bodi
weight
day
inocul
return
normal
weight
day
weight
match
trend
observ
pb
control
mice
figur
signific
differ
bodi
temperatur
group
pb
group
data
shown
clinic
sign
mat
fur
paralysi
death
tabl
follow
im
inocul
averag
bodi
weight
figur
temperatur
data
shown
mice
show
differ
compar
pb
control
group
mice
appear
clinic
normal
tabl
follow
im
administr
viru
detect
inject
site
drain
lymph
node
well
spleen
figur
e
g
muscl
high
level
mrna
grna
infecti
viru
measur
day
detect
level
gag
mrna
grna
persist
day
similarli
gag
mrna
grna
infecti
viru
detect
high
level
lymph
node
day
gag
mrna
infecti
viru
reach
undetect
level
day
respect
spleen
low
level
gag
mrna
detect
day
howev
grna
copi
persist
day
group
viral
load
similarli
detect
muscl
lymph
node
spleen
tissu
mice
follow
im
inject
figur
f
h
viral
rna
level
reach
undetect
level
day
group
harvest
tissu
mice
addit
time
point
day
highest
viral
load
observ
muscl
tissu
gag
mrna
grna
infecti
viru
level
peak
day
remain
rel
high
day
reach
undetect
level
day
gag
mrna
infecti
viru
day
grna
muscl
tissu
grna
infecti
viru
level
group
significantli
lower
group
time
point
lymph
node
viral
load
peak
day
decreas
undetect
day
infecti
viru
day
gag
mrna
low
level
grna
persist
day
viral
load
lymph
node
significantli
lower
group
gag
group
sever
time
point
final
grna
level
spleen
significantli
lower
group
group
nearli
time
point
observ
group
infecti
detect
spleen
tissu
day
mice
inocul
rout
either
pb
control
monitor
clinic
two
week
mice
group
lost
weight
steadili
day
time
lost
averag
initi
bodi
weight
figur
mice
appear
ill
tabl
mice
die
requir
euthanasia
began
gain
weight
follow
day
never
recov
day
level
although
averag
bodi
temperatur
mice
similar
pb
control
group
throughout
studi
data
shown
mice
group
mat
fur
develop
paralysi
total
die
euthanasia
diseas
tabl
contrast
mice
group
exhibit
sign
weight
loss
day
lost
averag
origin
bodi
weight
figur
averag
bodi
weight
gradual
return
initi
level
day
averag
bodi
temperatur
equival
pb
control
group
data
shown
addit
clinic
abnorm
tabl
mice
inocul
rout
viral
mrna
grna
detect
tissu
test
figur
respect
im
studi
gag
mrna
grna
infecti
viru
detect
highest
level
site
inocul
case
nasal
turbin
overal
viral
load
vari
among
differ
tissu
gag
mrna
copi
grna
copi
titer
infecti
viru
display
similar
kinet
tissu
type
furthermor
gag
mrna
grna
copi
nearli
equival
tissu
base
tissu
distribut
day
inoculum
appear
contain
nasal
turbin
lung
howev
small
number
viral
genom
gag
mrna
detect
brain
tissu
mice
day
presum
correspond
input
viru
gag
mrna
andor
grna
persist
longest
brain
day
nasal
turbin
lymph
node
day
one
mous
tissu
gag
mrna
detect
limit
day
infecti
viru
clear
tissu
day
except
brain
tissu
clear
day
mice
inocul
rout
detect
gag
mrna
grna
andor
infecti
viru
follow
tissu
brain
lung
nasal
turbin
lymph
node
figur
f
h
one
mous
gag
mrna
grna
copi
detect
limit
day
spleen
addit
one
mous
detect
grna
liver
day
figur
group
gag
mrna
grna
persist
longest
brain
day
nasal
turbin
day
one
mous
grna
detect
limit
day
lymph
node
day
infecti
viru
clear
lung
day
lymph
node
day
reach
undetect
level
nasal
turbin
brain
day
tissu
time
point
viral
load
significantli
lower
viru
overal
signific
differ
grna
level
figur
two
virus
observ
gag
mrna
final
infecti
viru
significantli
lower
mice
treat
compar
group
tissu
test
exclud
blood
undetect
time
point
test
particular
note
group
peak
infecti
titer
grna
level
detect
brain
tissu
day
lower
respect
group
fix
brain
section
examin
score
describ
materi
method
tabl
one
mous
inocul
viru
rout
exhibit
mild
inflamm
minim
neuropil
vacuol
day
two
section
examin
day
focal
minim
perivascular
inflamm
present
one
section
examin
one
six
mice
microscop
chang
observ
section
examin
mice
section
either
pb
group
day
high
dose
iv
inocul
mice
pb
control
includ
stringent
mean
analyz
vectorassoci
pathogen
widespread
dissemin
iv
group
mice
lost
initi
bodi
weight
day
slowli
regain
weight
cours
studi
figur
although
differ
bodi
temperatur
compar
pb
control
group
data
shown
mice
mat
fur
becam
paralyz
requir
euthanasia
tabl
mice
inocul
iv
rout
lost
bodi
weight
day
quickli
return
normal
weight
day
figur
differ
bodi
temperatur
compar
pb
group
data
shown
addit
clinic
sign
observ
mice
tabl
follow
iv
inocul
viru
detect
tissu
test
figur
e
g
particularli
qpcr
assay
blood
viral
load
peak
day
clear
day
highest
viral
load
detect
spleen
viru
clear
day
grna
remain
detect
day
liver
lung
kidney
muscl
viral
rna
peak
day
near
detect
limit
day
furthermor
infecti
viru
either
undetect
tissu
lung
kidney
clear
day
liver
muscl
viral
load
lymph
node
found
highest
day
persist
day
infecti
viru
day
gag
mrna
day
grna
last
time
point
taken
rout
final
viral
load
peak
brain
later
time
point
tissu
infecti
viru
clear
day
gag
mrna
persist
day
grna
persist
day
two
five
mice
viral
load
similarli
detect
tissu
test
iv
group
figur
f
h
group
highest
viral
load
also
observ
spleen
infecti
viru
clear
day
viral
rna
particularli
genom
persist
day
liver
lung
kidney
muscl
viral
rna
detect
day
low
level
grna
still
detect
liver
tissu
day
infecti
viru
undetect
tissu
except
muscl
day
lymph
node
infecti
viru
clear
day
viral
rna
remain
detect
day
figur
brain
viral
rna
peak
day
undetect
day
studi
grna
level
measur
group
significantli
lower
group
time
point
gag
mrna
level
although
latter
still
demonstr
signific
differ
two
group
figur
addit
tissu
time
point
infecti
viru
detect
level
significantli
lower
viru
figur
correspond
tissu
mice
inocul
iv
viru
minim
mild
multifoc
nonsuppur
inflamm
observ
three
five
mice
day
sampl
chang
observ
brain
day
mice
tabl
chang
present
brain
group
pb
control
mice
either
day
mice
consid
natur
host
vsv
use
anim
model
studi
vsv
pathogenesi
year
exquisit
sensit
mice
vsv
infect
proven
valuabl
research
tool
assess
virul
wild
type
attenu
strain
vsv
neurovirul
associ
vsv
infect
mice
well
studi
much
advanc
understand
biodistribut
vsv
mice
sinc
pioneer
work
sabin
olitski
present
use
highli
sensit
qpcr
assay
determin
highli
attenu
prototyp
virus
infect
limit
inocul
site
drain
lymphoid
organ
follow
im
inocul
widespread
infect
detect
virus
inocul
via
iv
rout
recombin
vsv
vector
current
develop
vaccin
vector
hiv
pathogen
live
viral
vector
must
suffici
attenu
administ
human
attenu
rvsv
test
studi
shown
well
toler
high
dose
highli
sensit
mous
model
three
rout
inocul
wherea
virul
prototyp
vsv
induc
signific
ill
follow
iv
inocul
attenu
prototyp
virus
show
minim
dissemin
follow
im
inocul
support
select
rout
futur
firstinman
clinic
trial
rvsv
vector
addit
attenu
rvsv
exhibit
advers
clinic
sign
weight
loss
paralysi
death
despit
widespread
tissu
distribut
iv
studi
consist
attenu
phenotyp
vitro
viru
replic
vigor
vivo
prototyp
viru
underscor
statist
signific
reduc
viral
load
major
tissu
group
compar
group
major
time
point
furthermor
despit
significantli
reduc
replic
level
attenu
viru
compar
prototyp
antigag
immun
respons
mice
inocul
im
attenu
viru
equal
greater
respons
induc
prototyp
vector
robust
immunogen
associ
use
attenu
vector
may
due
enhanc
express
gag
gene
natur
promoterproxim
posit
within
modifi
genom
compar
prototyp
vector
gag
gene
distal
genom
promot
inde
notion
support
studi
compar
gag
mrna
level
grna
level
two
vector
three
rout
inocul
grna
level
attenu
vector
significantli
lower
correspond
grna
level
prototyp
vector
tissu
time
point
observ
correspond
gag
mrna
level
compar
number
statist
signific
differ
panel
f
figur
restrict
spread
vsv
follow
im
inocul
adult
mice
origin
describ
sabin
olitski
similar
recent
report
infect
cattl
natur
host
bovin
studi
viral
spread
limit
inocul
site
drain
lymph
node
similar
manner
seen
im
inocul
mice
studi
limit
spread
cattl
experiment
model
natur
infect
may
explain
cattl
natur
infect
vsv
develop
neurolog
diseas
similarli
wt
vsv
nj
demonstr
restrict
abil
spread
neuron
tissu
follow
intraderm
inocul
adult
deer
mice
restrict
absent
juvenil
deer
mice
howev
murin
studi
describ
herein
neither
attenu
viru
virul
prototyp
viru
yield
advers
neurolog
find
evid
neuroinvas
im
inocul
sabin
olitski
propos
natur
barrier
spread
vsv
adult
mice
keep
vsv
enter
neuron
tissu
follow
im
inocul
idea
support
present
studi
interestingli
vsv
infect
detect
brain
anim
infect
iv
either
attenu
prototyp
viru
minim
detect
neuropatholog
observ
brain
despit
kinet
infect
indic
activ
replic
peak
day
brain
moreov
level
detect
brain
well
dose
requir
induc
lethal
enceph
follow
direct
intracrani
ic
inocul
ic
ld
less
pfu
studi
util
vsv
vector
express
gfp
pursu
determin
cellular
local
vsv
infect
brain
organ
follow
iv
inocul
vsv
administ
rout
inocul
pathogen
mice
especi
young
mice
juvenil
mice
succumb
lethal
enceph
follow
transmiss
vsv
olfactori
epithelium
olfactori
bulb
via
olfactori
nerv
result
report
herein
demonstr
inocul
virul
prototyp
viru
induc
weight
loss
clinic
sign
diseas
observ
system
infect
follow
iv
inocul
follow
inocul
viral
load
peak
day
brain
sinc
whole
brain
homogen
use
viru
analysi
studi
possibl
infecti
viru
viral
rna
may
concentr
olfactori
bulb
region
brain
peak
viru
titer
mg
tissu
seen
brain
homogen
anim
receiv
prototyp
rvsv
rout
time
higher
ic
ld
yet
mice
show
limit
morbid
minim
neuropatholog
possibl
sever
neuropatholog
occur
subset
mice
die
follow
inocul
prototyp
vector
unabl
assess
brain
viral
load
histopatholog
contrast
mice
receiv
attenu
rvsv
intranas
exhibit
significantli
lower
level
infecti
viru
brain
exhibit
sign
morbid
mortal
furthermor
less
system
spread
viru
follow
instil
attenu
viru
well
detect
viremia
find
agreement
analysi
relat
attenu
vsv
vector
show
compar
wt
vector
truncat
cytoplasm
tail
vsv
vector
spread
significantli
less
lymph
node
organ
inocul
rout
previou
studi
address
persist
vsv
follow
infect
cattl
natur
host
experiment
rodent
model
order
understand
natur
vsv
persist
anim
follow
infect
convalesc
letchworth
colleagu
experiment
infect
hamster
cattl
vsv
nj
serotyp
viral
genom
rna
determin
specif
rtpcr
persist
brain
liver
spleen
kidney
lung
tissu
anim
sever
month
follow
infect
infecti
viru
recov
tissu
studi
describ
herein
highli
sensit
qpcr
assay
viral
rna
detect
presenc
viral
grna
well
mrna
virus
anim
tissu
long
clearanc
infecti
virus
among
tissu
lymph
node
major
site
persist
vsv
genom
especi
follow
inocul
recent
studi
mice
show
compar
wt
vector
attenu
singlecycl
vsv
vector
spread
persist
significantli
less
follow
inocul
reduc
spread
persist
correl
reduct
immun
respons
rout
nonetheless
vector
show
persist
genom
rna
lymph
node
clearanc
infecti
viru
explain
persist
viral
grna
lymph
node
rose
et
al
suggest
two
possibl
model
low
level
longterm
viral
replic
persist
rna
contain
within
nucleocapsid
clear
slowli
addit
recent
studi
report
persist
vsv
encod
antigen
lymph
node
six
week
inocul
author
suggest
persist
nucleocapsid
undergo
low
level
transcript
translat
result
antigen
express
data
support
model
persist
nucleocapsid
may
undergo
low
level
transcript
abl
detect
grna
case
gag
mrna
tissu
particularli
lymph
node
long
infecti
viru
disappear
attenu
rvsv
vector
well
toler
nonpathogen
even
system
infect
demonstr
near
absenc
vectorassoci
pathogen
attenu
construct
highli
permiss
anim
model
furthermor
local
dissemin
viru
deliv
intramuscularli
would
suggest
im
prefer
rout
administr
firstinman
evalu
find
aid
develop
clinic
evalu
attenu
vsv
vector
suggest
possibl
mechan
enhanc
immunogen
attenu
rvsv
vector
tabl
clinic
sign
diseas
mice
follow
inocul
